PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: NAPRx®

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

The NAPRX CNPR Certification Program Earns E-Learning Award from the PRMA Institute - The real power of the NAPRX CNPR Certification is that sales professionals learn to communicate with physicians. The NAPRX CNPR certification was recognized for the award after a rigorous evaluation of the NAPRX CNPR course’s usability and design
The NAPRX CNPR Certification Program Earns E-Learning Award from the PRMA Institute

 

NewswireToday - /newswire/ - Washington, DC, United States, 2012/02/03 - The real power of the NAPRX CNPR Certification is that sales professionals learn to communicate with physicians. The NAPRX CNPR certification was recognized for the award after a rigorous evaluation of the NAPRX CNPR course’s usability and design.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The AME and Pharmaceutical Training Group, Inc. is pleased to announce that the CNPR Certification has been awarded a prestigious E-Learning Courseware award (ECC) by the PRMA Institute.

Thousands of entry level pharmaceutical sales candidates have benefited from the CNPR Certification program. Now conveniently available online and at over 300 universities; this course trains, educates and certifies pharmaceutical sales candidates for a career in pharmaceutical sales.

The NAPRx® has developed the CNPR program for the industry in 1998 to educate candidates so that they will be able to differentiate themselves from other candidates and meet job requirmements. The majority of entry level candidates do not know enough about the pharmaceutical industry, drug patents, FDA regulations, CDER regulations, laws governing the pharmaceutical industry, the anatomy, pharmaceutical terms and abbreviations, drug sampling rules, effective physician selling skills, who to contact at pharmaceutical companies, general interview questions, etc.

Qualified or aspiring pharmaceutical sales applicants should be familiar with clinical pharmacology, medical terminology, plus rules and regulations for selling pharmaceuticals to effectively sell to healthcare professionals. Applicants who have no previous pharmaceutical sales experience but who have acquired industry sales training, pharmaceutical product knowledge, managed care guidelines plus selling regulations will always be more qualified versus others without it. No successful pharmaceutical sales professional will be successful unless they have to up-to-date pharmaceutical industry education and product knowledge. Our association provides vocational pharmaceutical sales education (CNPR® Certification) that candidates add to their resume to attract pharmaceutical employers and qualify for pharmaceutical sales interviews.

The real power of the NAPRX CNPR Certification is that sales professionals learn to communicate with healthcare professionals, physicians and pharmacists. The NAPRX CNPR certification was recognized for the award after a rigorous evaluation of the NAPRX CNPR course’s usability and instructional design. The award indicates that the NAPRX CNPR Certification demonstrates the characteristics associated with excellent instruction.

Brad Sullivan a CNPR Certification Coordinator from the NAPRx has said,“After spending over 13 years refining the course and several months developing the online version, it is hard how to put in words how much this certification means to the pharmaceutical sales industry. We have the world’s first and only certified course for entry level pharmaceutical sales candidates.”

The National Association of Pharmaceutical Representatives® (NAPRx®) is the United States largest trade association for sales reps, sales managers and sales trainers who work in the pharmaceutical industry. NAPRx® represents sales representatives who work in the pharmaceutical industry and provides Continuing Medical Education to its members as well as candidates who look to enter a pharmaceutical sales career. The CNPR® Certification Program is available by correspondence directly through the NAPRx® (napsronline.org) or can also be taken at over 300 universities/colleges in the United States.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: NAPRx®

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


The NAPRX CNPR Certification Program Earns E-Learning Award from the PRMA Institute

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Brad Sullivan - NAPSRonline.org 
1-800-913-0701 questions[.]napsronline.org
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any NAPRx® securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From NAPRx® / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow Ltd

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)